SEC Form 4 · accession 0001179022-18-000012
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin D Freeman
Director
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 8:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2018 | P | 2,000 | $4.0955 | A | 16,000 | I | IRA |
| Common Stock | holding | — | — | — | 22,043 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 6,000 shares that the reporting person previously mistakenly reported as being held directly and which should have been reported as being held indirectly, by the reporting person's IRA.